QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.088914v1 315/2/839    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carter, A. A. Articles by Hill, S. J. Search for Related Content PubMed PubMed Citation Articles by Carter, A. A. Articles by Hill, S. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PROPRANOLOL HYDROCHLORIDE

CELLULAR AND MOLECULAR

Characterization of Isoprenaline- and Salmeterol-Stimulated Interactions between ₂-Adrenoceptors and -Arrestin 2 Using -Galactosidase Complementation in C2C12 Cells

Institute of Cell Signalling, Medical School, Queens Medical Centre, Nottingham, United Kingdom

-Arrestin is an adaptor protein that has been shown to couple G protein-coupled receptors (GPCRs) to clathrin-coated pits and target them for subsequent internalization. More recently, -arrestin 2 has also been shown to be involved in the activation of mitogen-activated protein kinase cascades by G protein-coupled receptors independently of G protein activation. Direct interactions between proteins can be monitored using enzyme complementation between two inactive deletion mutants of -galactosidase (-gal; and ). In the present study, we have used fusion proteins of the human ₂-adrenoceptor (C-terminal -gal ) and -arrestin 2 (-gal ) to study directly the pharmacology of this interaction in C2C12 cells expressing the ₂-adrenoceptor--gal fusion protein at low physiological levels (38.2 ± 2.7 fmol · mg protein^-1). Isoprenaline, noradrenaline, and adrenaline (-log EC₅₀ = 5.9, 5.5, and 5.7, respectively) stimulated an association between the ₂-adrenoceptor and -arrestin 2 at much higher concentrations than required for activation of cAMP accumulation (-log EC₅₀ = 7.6, 6.3, and 7.7, respectively). This was sensitive to inhibition by the ₂-adrenoceptor antagonists propranolol, timolol, and ICI 118551. Both salbutamol and terbutaline behaved as partial agonists of -gal complementation. Furthermore, the long-acting ₂-agonist salmeterol (-log K_D for inhibition of [³H]CGP12177 binding = 8.7) behaved as an antagonist of isoprenaline-stimulated ₂-adrenoceptor-arrestin 2 interactions (-log K_D = 8.0), whereas acting as a full agonist of cAMP accumulation in the same cells (-log EC₅₀ = 9.2). These data suggest that salmeterol can discriminate between receptor-G_S protein and receptor-arrestin 2 complexes (in terms of efficacy and affinity) in a way that is favorable for its long duration of action.

Address correspondence to: Professor Stephen J. Hill, Institute of Cell Signaling, Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK. E-mail: stephen.hill{at}nottingham.ac.uk.

This article has been cited by other articles:

				R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261. [Abstract] [Full Text] [PDF]